Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 55, 2020 - Issue 5
Submit an article Journal homepage
125
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms

Satoshi KotaniDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Nobuhiko FukubaDepartment of Internal Medicine, Izumo City General Medical Center, Izumo, Japan;
,
Kousaku KawashimaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan; ;Inflammatory Bowel Disease Center, Shimane University Hospital, Izumo, Japan;
,
Yoshiyuki MishimaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Hiroki SonoyamaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Eiko OkimotoDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Yasumasa TadaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Akihiko OkaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Yuji TamagawaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Naoki OshimaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Tsuyoshi MishiroDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Hiroshi TobitaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Kotaro ShibagakiDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Ichiro MoriyamaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Norihisa IshimuraDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan;
,
Yoshinori KushiyamaDivision of Gastroenterology, Matsue Red Cross Hospital, Matsue, Japan;
,
Hirofumi FujishiroDivision of Gastroenterology, Shimane Prefectural Central Hospital, Izumo, Japan
&
Shunji IshiharaDepartment of Internal Medicine II, Shimane University School of Medicine, Izumo, Japan; ;Inflammatory Bowel Disease Center, Shimane University Hospital, Izumo, Japan; Correspondence[email protected]
 show all
Pages 560-564 | Received 24 Feb 2020, Accepted 23 Apr 2020, Published online: 15 May 2020

References

  • Katsanos KH, Papamichael K, Feuerstein JD, et al. Biological therapies in inflammatory bowel disease: beyond anti-TNF therapies. Clin Immunol. 2019;206:9–14.
  • Verstockt B, Ferrante M, Vermeire S, et al. New treatment options for inflammatory bowel diseases. J Gastroenterol. 2018;53:585–590.
  • Neurath M. Current and emerging therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol. 2017;14:688–688.
  • Keohane J, O’Mahony C, O’Mahony L, et al. Irritable bowel syndrome–type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol. 2010;105:1789–1794.
  • Simrén M, Axelsson J, Gillberg R, et al. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterology. 2002;97:389–396.
  • Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1474–1482.
  • Fujiwara Y, Arakawa T. Overlap in patients with dyspepsia/functional dyspepsia. J Neurogastroenterol Motil. 2014;20:447–457.
  • Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? NeurogastroenterolMotil. 2012;24:895–913.
  • Suzuki H, Hibi T. Overlap syndrome of functional dyspepsia and irritable bowel syndrome – are both diseases mutually exclusive? J Neurogastroenterol Motil. 2011;17:360–365.
  • Fukuba N, Ishihara S, Tada Y, et al. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study. Scand J Gastroenterol. 2014;49:674–680.
  • Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. BMJ. 1989;298:82–86.
  • Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390.
  • Kanazawa M, Nakajima S, Oshima T, et al. Validity and reliability of the Japanese version of the Rome III diagnostic questionnaire for irritable bowel syndrome and functional dyspepsia. J Neurogastroenterol Motil. 2015;21:537–544.
  • Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in Japan and in the world. J Neurogastroenterol Motil. 2015;21:320–329.
  • Yao X, Yang YS, Cui LH, et al. The overlap of upper functional gastrointestinal disorders with irritable bowel syndrome in Chinese outpatients: a multicenter study. J Gastroenterol Hepatol. 2016;31:1584–1593.
  • Matsuzaki J, Suzuki H, Fukushima Y, et al. High frequency of overlap between functional dyspepsia and overactive bladder. NeurogastroenterolMotil. 2012;24:821–827.
  • Kaji M, Fujiwara Y, Shiba M, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol. 2010;25:1151–1156.
  • Wang A, Liao X, Xiong L, et al. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol. 2008;8:43.
  • Choi YJ, Kim N, Yoon H, et al. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses. J Gastroenterol Hepatol. 2017;32:1553–1561.
  • Ford AC, Marwaha A, Lim A, et al. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010;8:401–409.
  • Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group. N Engl J Med. 1997;337:1029–1035.
  • Singleton JW, Law DH, Kelley ML, Jr, et al. National Cooperative Crohn’s Disease Study: adverse reactions to study drugs. Gastroenterology. 1979;77:870–882.
  • Hisabe T, Matsui T, Miyaoka M, et al. Diagnosis and clinical course of ulcerative gastroduodenal lesion associated with ulcerative colitis: possible relationship with pouchitis. Dig Endosc. 2010;22:268–274.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.